In prostate cancer, ESM-1 expression is significantly elevated in patients with high Gleason grades and Gleason scores, the main method used to stage prostate cancer, suggesting ESM-1 is a useful biomarker for cancer diagnosis (74). The gene discussed is ESM1; the disease is Familial prostate cancer.